Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
After 20 years of studies, researchers will begin the first human trial for a nasal vaccine aimed at preventing and slowing Alzheimer’s disease. Sixteen participants at Boston’s Brigham and Women’s Hospital will receive two doses of the vaccine one week apart. CBS Boston’s Zinnia Maldonado has more.
View CBS News In
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.